New Asthma Research Opposes Current Drug Treatment, Study Suggests

Just as the FDA is reconsidering the use of stimulants to treat asthma, a new study offers evidence to support a theory that an opposite approach to asthma treatment may be in order. Scientists are investigating whether beta-2 adrenoreceptor antagonists (beta blockers) might be a safer, more effective strategy for long-term asthma management. A new study shows the absence of asthma-like symptoms in mice lacking the key gene that produces the receptor.

Read the whole article on Science Daily

More from Science Daily